Mazdutide Pen is an innovative multi-receptor agonist designed for a comprehensive effect on metabolism and body weight regulation. The drug simultaneously affects two types of receptors: GLP-1 (glucagon-like peptide-1) and ...
Mazdutide Pen is an innovative multi-receptor agonist designed for a comprehensive effect on metabolism and body weight regulation. The drug simultaneously affects two types of receptors: GLP-1 (glucagon-like peptide-1) and glucagon receptors, providing a dual action: suppressing hunger and accelerating the body's energy expenditure processes. Due to this combination, fat breakdown is enhanced, metabolism increases, and the balance of nutrients improves in favor of muscle preservation.
The convenient pen form ensures precise dosing, stable absorption of the drug, and comfort during prolonged use.
Description
Mechanism: GLP-1 suppresses appetite/slows stomach + glucagon accelerates lipolysis/thermogenesis; -15-20% weight loss in 6-12 months, visceral fat ↓, glycemia normalizes.
Key Properties and Benefits of Mazdutide
-
Effectively reduces appetite by activating GLP-1 signals.
-
Enhances fat breakdown processes and decreases the total mass of fat deposits.
-
Increases the body's sensitivity to glucose and overall metabolic rate.
-
Supports muscle tissue even under calorie deficit.
-
Improves the body's adaptation to physical exertion and stress resistance.
Why Choose Mazdutide?
-
Dual effect: reduced food intake and increased energy expenditure.
-
High efficacy in people with obesity (BMI >30), metabolic disorders, and insulin resistance.
-
Promotes the preservation of muscle mass during weight loss.
-
Rapid achievement of sustainable results and stabilization of metabolic indicators.
-
Suitable for long-term therapy and support of dietetic programs.
Stacks (top-3 for weight loss)
|
Stack |
Effect |
Dose/week |
|---|---|---|
|
Mazdutide + AOD-9604 |
Lipolysis x2 |
3 mg + 2 mg |
|
Mazdutide + Tesofensine |
Appetite/energy |
4 mg + 1 mg |
|
Mazdutide + CJC-1295 |
Metabolism + GH |
5 mg + 2 mg |
Administration and Treatment Protocols
Subcutaneously in abdomen/thigh; start with a low dose (against nausea).
1. Standard weight loss (loading):
|
Weeks |
Dose |
Frequency |
|---|---|---|
|
1-4 |
1-2 mg |
1x/wk |
|
5-12 |
3-6 mg |
1x/wk |
|
13+ |
4-9 mg |
1x/wk |
2. Maintenance (after -15% weight): 2-4 mg/week.
3. With liver/T2D: 3 mg + metformin, ALT monitoring.
The drug is ideal for patients seeking to significantly reduce weight, improve health, and achieve sustainable results within comprehensive weight loss protocols, lifestyle change programs, and forming an optimal balance of nutrition and physical activity.
Information
Smart Benefits.
Maximum Impact.
The Science of Longevity in Detail
